wet AMD - Classic CNVM mild vision loss
|
|
80 year old female She did not notice a problem but then when she saw you her vision in the right eye was hazy. The left eye was being watched because of eyelid herpes. The right eye has always been the weaker eye. She has not noticed a vision change in the right eye.
Shingles post-herpetic neuralgia over left eye for 2 years
VA OD: Dcc20/40+1 NccJ3
VA OS: Dcc20/25-2 NccJ1-1
IOP: TP: OD:17 OS:21
Anterior segment unremarkable (PCIOLs)
Vision improved to 20/25 after two Avastin shots and at 1 year she is getting treatment every 2 months
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 30380 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29580 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 28380 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 32080 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 30280 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 28480 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 32480 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 27580 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29980 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29380 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 27980 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 30580 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 28080 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29880 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 28480 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 33780 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 31180 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 31780 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 33780 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 30080 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 33380 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 26680 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 26580 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29880 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 27280 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
|
|
|
|
|
80 year old female She did not notice a problem but then when she saw you her vision in the right eye was hazy. The left eye was being watched because of eyelid herpes. The right eye has always been the weaker eye. She has not noticed a vision change in the right eye.
Shingles post-herpetic neuralgia over left eye for 2 years
VA OD: Dcc20/40+1 NccJ3
VA OS: Dcc20/25-2 NccJ1-1
IOP: TP: OD:17 OS:21
Anterior segment unremarkable (PCIOLs)
Vision improved to 20/25 after two Avastin shots and at 1 year she is getting treatment every 2 months
